Stocks Aim To Attain Street Attentions: Texas Instruments (NASDAQ:TXN), Ocular Therapeutix (NASDAQ:OCUL)

Texas Instruments Incorporated (NASDAQ:TXN) [Trend Analysis] luring active investment momentum, shares an increase 1.78% to $77.08. Texas Instruments Incorporated (TXN) declared that promotion of Brian Crutcher to chief operating officer. He has been executive vice president responsible for all business and sales operations, Kilby Labs and information technology. As COO, he adds oversight of global technology and manufacturing operations to current duties.

Crutcher joined the company in 1996 and during his first 10 years served in a variety of leadership roles in the sales organization, including vice president in charge of the Americas. He later moved into business operations and at separate times led each of the company’s two business sections, Analog and Embedded Processing. The total volume of 8.48 Million shares held in the session was surprisingly higher than its average volume of 5266.76 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 9.70%, and looking further price to next year’s EPS is 8.32%. While take a short look on price to sales ratio, that was 5.88 and price to earnings ratio of 24.49 attracting passive investors.

Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) [Trend Analysis] runs in leading trade, it plunging -9.01% to traded at $6.87. The firm has price volatility of 6.27% for a week and 5.80% for a month. Ocular Therapeutix, Inc. (OCUL) reported that pricing of a registered underwritten public offering of 3,571,429 shares of its common stock at a public offering price of $7.00 per share pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission (SEC).

All of the shares in the offering are to be sold by the Company. Cantor Fitzgerald & Co. is acting as the sole bookrunner for the offering. The offering is expected to close on or about January 27, 2017, subject to customary closing conditions. Before investing in the offering, interested parties may read the prospectus supplement and the accompanying prospectus for the offering and the other documents the Company has filed with the SEC, which are incorporated by reference in the prospectus supplement and the accompanying prospectus for the offering and provide more complete information about the Company and the offering. Narrow down four to firm performance, its weekly performance was -12.93% and monthly performance was -16.22%. The stock price of OCUL is moving down from its 20 days moving average with -15.50% and isolated negatively from 50 days moving average with -20.30%.


About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Leave a Reply

Your email address will not be published. Required fields are marked *